• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下颌骨放射性骨坏死的长期随访。

Long-term follow-up of osteoradionecrosis of the mandible.

机构信息

Department of Oral and Maxillofacial Surgery, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Oncology, Institute of Clinical Sciences at Gothenburg University and Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

Acta Odontol Scand. 2024 Jan;82(1):48-54. doi: 10.1080/00016357.2023.2257316. Epub 2023 Dec 28.

DOI:10.1080/00016357.2023.2257316
PMID:37772879
Abstract

AIM

Investigating the prevalence of mandibular ORN in a single Swedish Oncology Center.

METHODS

A total of 450 patients, treated with radiotherapy for squamous cell carcinoma in the oropharynx between 2004 and 2014 were included. Three different techniques of radiotherapy were studied. ORN diagnosis was set when clinical signs according to Marx were observed, or if radiological signs were staged according to Schwartz and Kagan.

RESULTS

Using the staging system, 90 patients (20%) were diagnosed with ORN. The mean age of the ORN patients was 56.6 years, the older the patient the lower the risk of developing ORN ( = .01). The risk of developing ORN for patients receiving Intensity Modulated Radiotherapy was lower compared to patients treated with the other techniques in the multivariable analysis. Brachytherapy significantly increases the risk of ORN. The risk of ORN increased by 8% each year after radiation ( = .04). The mean time to the ORN diagnosis was 3.9 years. In the multivariate analysis, the risk of ORN increased by 13% each year after radiation ( = .0013).

CONCLUSION

The mean radiation dose was of greater importance for the risk of ORN than the maximum dose. Elderly people with oropharyngeal cancer were less prone to develop ORN.

摘要

目的

调查单一瑞典肿瘤中心下颌骨放射性骨坏死(ORN)的患病率。

方法

共纳入 450 例于 2004 年至 2014 年间因口咽鳞癌接受放射治疗的患者。研究了三种不同的放射治疗技术。当根据 Marx 的临床表现观察到 ORN 诊断,或根据 Schwartz 和 Kagan 的影像学分期时,诊断为 ORN。

结果

使用分期系统,90 例(20%)患者被诊断为 ORN。ORN 患者的平均年龄为 56.6 岁,年龄越大,发生 ORN 的风险越低( = .01)。在多变量分析中,与接受其他技术治疗的患者相比,接受调强放射治疗的患者发生 ORN 的风险较低。近距离放射治疗显著增加 ORN 的风险。放射治疗后每年 ORN 的风险增加 8%( = .04)。ORN 诊断的平均时间为 3.9 年。在多变量分析中,放射治疗后 ORN 的风险每年增加 13%( = .0013)。

结论

对于 ORN 风险而言,放射剂量均值比最大剂量更为重要。患有口咽癌的老年人发生 ORN 的可能性较低。

相似文献

1
Long-term follow-up of osteoradionecrosis of the mandible.下颌骨放射性骨坏死的长期随访。
Acta Odontol Scand. 2024 Jan;82(1):48-54. doi: 10.1080/00016357.2023.2257316. Epub 2023 Dec 28.
2
Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.调强放疗治疗口咽癌患者的下颌骨放射性骨坏死。
Cancer. 2017 Oct 1;123(19):3691-3700. doi: 10.1002/cncr.30803. Epub 2017 Jun 13.
3
Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer.口咽癌患者的颌骨放射性骨坏死与下颌骨受照剂量。
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):415-20. doi: 10.1016/j.ijrobp.2012.05.032. Epub 2012 Jul 12.
4
Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.接受调强放疗的口咽癌患者下颌骨放射性骨坏死的剂量-体积相关性:病例匹配比较结果
Radiother Oncol. 2017 Aug;124(2):232-239. doi: 10.1016/j.radonc.2017.06.026. Epub 2017 Jul 18.
5
Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.口腔和口咽癌患者下颌骨放射性骨坏死的危险因素及剂量-效应关系。
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1084-91. doi: 10.1016/j.ijrobp.2008.12.052. Epub 2009 Mar 26.
6
Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: incidence and risk factors.口腔和口咽鳞状细胞癌下颌骨放射性骨坏死:发生率和危险因素。
Otolaryngol Head Neck Surg. 2011 May;144(5):726-32. doi: 10.1177/0194599810396290.
7
The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.接受调强放射治疗(IMRT)的口腔和口咽癌患者颌骨放射性骨坏死的患病率及相关危险因素:纪念斯隆凯特琳癌症中心的经验
Oral Oncol. 2017 Jan;64:44-51. doi: 10.1016/j.oraloncology.2016.11.015. Epub 2016 Dec 3.
8
Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.口腔癌术后放疗后骨放射性坏死:回顾性队列研究。
Oral Oncol. 2022 Oct;133:106056. doi: 10.1016/j.oraloncology.2022.106056. Epub 2022 Aug 4.
9
Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment.在口咽癌治疗中,对放射性骨坏死建模时考虑分割和不均匀剂量分布。
Radiother Oncol. 2023 Nov;188:109889. doi: 10.1016/j.radonc.2023.109889. Epub 2023 Sep 1.
10
Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy.传统放疗与调强放疗的放射性骨坏死发生率比较。
Head Neck. 2016 Nov;38(11):1695-1702. doi: 10.1002/hed.24505. Epub 2016 May 31.

引用本文的文献

1
Predictive modelling of mandibular osteoradionecrosis in head and neck cancer patients: clinical and dosimetric insights.头颈部癌患者下颌骨放射性骨坏死的预测模型:临床与剂量学见解
Clin Oral Investig. 2025 May 26;29(6):313. doi: 10.1007/s00784-025-06385-3.
2
Bridging the gap - Establishing a dental-oncology service in a cancer centre.弥合差距 - 在癌症中心建立牙科肿瘤服务。
Support Care Cancer. 2024 Sep 28;32(10):693. doi: 10.1007/s00520-024-08872-x.
3
Prevention of osteoradionecrosis in patients with head and neck cancer treated with radiation therapy.
头颈部癌患者接受放射治疗时放射性骨坏死的预防
Head Neck. 2025 Feb;47(2):472-484. doi: 10.1002/hed.27927. Epub 2024 Aug 30.